Department of Medical Oncology for Melanoma and Sarcoma

Peking University Cancer Hospital, Beijing
黑色素瘤与肉瘤内科 · Medical Oncology

Established in 2005, this department specializes in the medical management of malignant melanoma, other skin cancers, and soft tissue sarcomas. It integrates clinical care with research through a dedicated translational laboratory. The team focuses on immunotherapy, resistance mechanisms, anti-angiogenesis, and targeted gene therapy. As the lead unit for Chinese melanoma treatment guidelines, the department conducts extensive clinical trials. It has contributed to the approval of several new drugs in China, including vemurafenib, dabrafenib/trametinib, and pembrolizumab. The department also helps shape international standards, with findings presented at major conferences such as ASCO and ESMO.

What the department treats

Key facts

As described by the hospital.

Team

7 doctors listed.

We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.

Not sure which specialist is right?

Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.

Get a specialist opinion